Explore insights into early-phase drug development with expert advice, case studies, and practical considerations for pharmaceutical and biotechnology companies.
Issue 42 — Managing the Complexities of Glucagon -like Peptide-1 Receptor Agonist Drug Development
49 mins • Nov 15, 2024
Charts
This show is not currently ranked in any charts.
Episódios recentes
![](https://files.podcastos.com/shows/wyz79c/jpeg256-0ac7422a.jpg)
Nov 15, 2024
Issue 42 — Managing the Complexities of Glucagon -like Peptide-1 Receptor Agonist Drug Development
49 mins
![](https://files.podcastos.com/shows/wyz79c/jpeg256-0ac7422a.jpg)
Sep 20, 2024
Issue 41 — Immunomodulation Assessments for Clinical Trials
31 mins
![](https://files.podcastos.com/shows/wyz79c/jpeg256-0ac7422a.jpg)
Sep 20, 2024
Issue 40 — Analytical Testing: Maximizing API Bioavailability
27 mins
![](https://files.podcastos.com/shows/wyz79c/jpeg256-0ac7422a.jpg)
May 6, 2024
Issue 39 — Considerations for Nonclinical Dermal Studies: Advancing to Phase I
17 mins
![](https://files.podcastos.com/shows/wyz79c/jpeg256-0ac7422a.jpg)
Apr 2, 2024
Issue 38 — Optimal Preclinical Formulation and Drug Product Manufacture
24 mins
![](https://files.podcastos.com/shows/wyz79c/jpeg-fda7629d.jpg)
Idioma
Inglês
País
Estados Unidos
Categorias
Feed Host
Website
Feed
Solicitar uma atualização
As atualizações podem levar alguns minutos.